• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research And Markets: Examine Now This Overview Of The Generally Accepted Pharmaceutical Approaches To Diabetes And Obesity That Are Used Today

Posted on: Monday, 15 November 2004, 06:00 CST

The Purpose of This Report is Not Only to Provide an Overview of Diabetes but Also to Present a Review of the Pharmaceutical Market with the Latest Information Regarding Pharmaceutical Products and Industry Trends. It Will Not Only Quantify but Also Qualify, for You, the Market of Diabetes Therapies as an Area of Research and Investment.

Research and Markets (http://www.researchandmarkets.com/reports/c8687) has announced the addition of Overview and Analysis of the Diabetes Market to their offering.

The purpose of this report is to describe the specific market segment of the pharmaceutical market of diabetes, metabolic syndrome, and cardiovascular disease.

This report reviews and evaluates all of the generally accepted pharmaceutical approaches to diabetes and obesity that are currently used today. The report is arranged to provide the reader with an overview of the diabetes drug market accompanied by analysis and forecasts by product type and application. Information on the leading diabetes drugs for the treatment of type 1 and 2 diabetes as well as a brief look at the drugs for treating the complications associated with diabetes will be presented in this report.

Forecasts of the market and an analysis of products in the worldwide prescriptions market will provide a basis for understanding the significance of past developments and future possibilities within this therapeutic category.

The principle objectives of this report are to:

-- Identify viable technology drivers through a comprehensive look at various platform technologies for diabetes, obesity and metabolic diseases.

-- Obtain a complete understanding of the chief diabetes, obesity and metabolic diseases tests - predictive, screening, prognostic, monitoring, pharmacogenomic, and theranostic - from their basic principles to their applications.

-- Discover feasible market opportunities via an identification of high-growth applications in different therapeutic areas, with a focus on the biggest and expanding markets for diabetes, obesity and metabolic diseases.

-- Focus on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including forecasts for growth.

-- Review the blood glucose testing market including definitions, technology and trends.

-- Market figures regarding the current value of the diabetes drug market are taken from the most recently available data of the global pharmaceutical industry. Projections and forecasts for the future of the diabetes market ranges from 2004 to 2010

By purchasing this report, you will have:

1. An improved understanding of the current state and future of the diabetes market

2. The latest information on the leading companies engaged in R&D and products in the pipeline

3. The leading perspective of recent drug developments and revelations

4. Knowledge of the diabetes market as an area of growth, research and investment

This report will cover the following categories of diabetes drugs:

-- Rapid Acting Insulin

-- Short Activity Insulin

-- Intermediate Acting Insulin

-- Long Acting Insulin

-- Ultra Long Acting Insulin

-- Insulin Mixtures

-- Sulfonylureas

-- Meglitinides

-- Biguanides

-- Thiazolidinediones

-- Alpha-Glucosidase Inhibitors

Analysis includes the use of charts and graphs measuring product growth and trends within the marketplace. In addition, a discussion of research into the illness provides the reader with a deeper understanding of the possibilities for future treatment and avenues for possible research and development budgets. Company-specific information, including sales figures, drug pipeline status, and research and development trends is provided throughout the report.

-- Assess the diabetes, obesity and metabolic disease market drivers and bottlenecks, from the perspective of the medical and scientific communities.

-- Discuss the potential benefits of diabetes, obesity and metabolic disease market for various sectors of the medical and scientific community.

-- Establish the current total market size and future growth of the diabetes, obesity and metabolic disease market and analyze the current size and growth of therapeutic segments.

-- Provide current and forecasted market shares by company.

-- Discuss profit / business opportunities by therapeutic segment.

-- Provide strategic recommendations for near term business opportunities.

-- Assess current commercial uses of diabetes, obesity and metabolic disease market.

-- Assess the blood glucose testing business mode

We answer the following questions in this report:

-- What are the near term business opportunities in the diabetes, obesity and metabolic disease market?

-- What are the current and forecasted sizes of the diabetes, obesity and metabolic disease market?

-- What are the business models currently used by companies in diabetes, obesity and metabolic disease market?

-- How will drug manufacturers, researchers, physicians, patients and payers influence the diabetes, obesity and metabolic disease market?

-- What are the drivers and bottlenecks influencing the diabetes, obesity and metabolic disease market?

-- What are the technologies used in diabetes, obesity and metabolic disease therapies?

-- Who holds the proprietary rights to diabetes, obesity and metabolic disease market therapeutic technology?

-- What are current applications of this technology?

-- What regulatory processes must diabetes, obesity and metabolic disease therapeutics undergo in the U.S., Japan and Europe?

-- How will new diabetes, obesity and metabolic disease therapies change treatment and payment paradigms?

-- How will litigation concerns increase physician use of diabetes, obesity and metabolic disease therapies?

-- How will diabetes, obesity and metabolic disease therapies reduce adverse drug reactions and decrease total patient care cost?

-- How will diabetes, obesity and metabolic disease therapies reduce health care expenditures?

-- How will drug development cost and time decrease with diabetes, obesity and metabolic disease therapy use?

For more information visit http://www.researchandmarkets.com/reports/c8687

Source: Business Wire

More News in this Category